Ondansetron
Product Images NDC 33358-512

2 FDA label images from Rxchange Co. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 33358-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron8mg (Ondansetron8mg)

Ondansetron8mg (Ondansetron8mg)
Ondansetron 8 mg tablet bottle label from RxChange Co. The label specifies #30 OD tablets with item number 0512-30 and NDC 33358-512-30. It includes manufacturer information (Aurobindo Pharma Ltd., India), lot number, expiration placeholder, storage instructions (20-25°C), and a caution to keep out of reach of children.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron showing its molecular arrangement with characteristic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.